Novozymes went slightly up except for one division

The biofuel division was the only part of Novozymes to suffer a setback in 2016, according to the annual report on a "challenging year", in which the enzyme producer kicks off a round of firings and a large-scale share buy-back program.

Photo: Novozymes/ PR

Overall, Novozymes made progress in 2016. The enzyme producer's revenue increased slightly by 1 percent to DKK 14,142 million (EUR 1,902 million) while the result landed a good 7 percent above 2015 at DKK 3,881 before taxes, according to the annual report presented Wednesday morning.

However, the progress is not a result of positive trends in the biofuel business. As the only one of Novozyme's five divisions, it suffered an unsurprising setback with revenue of DKK 2,438 million, which is 4 percent less than the previous year.

Read the whole article

Get 14 days free access.

No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from EnergyWatch

Siemens Gamesa's deep financial woes are halfway self-inflicted

Despite successfully forwarding the external costs to customers, onshore wind projects valued at EUR 2bn are being delivered at zero-profit margins in the years to come, according to the turbine maker’s CEO. Here and there, things might have moved a bit too fast.

Siemens Gamesa drags down majority shareholder

Despite better sales than expected in the gas business, Siemens Energy downgrades its full-year guidance in the wake of Siemens Gamesa’s announcement of potentially massive losses in 2022.

Further reading

Related articles

Latest News

See all jobs